IT1252717B - Preparato farmaceutico da utilizzare quale trattamento coadiuvante della dermatite seborroica anche in soggetti hiv positivi - Google Patents

Preparato farmaceutico da utilizzare quale trattamento coadiuvante della dermatite seborroica anche in soggetti hiv positivi

Info

Publication number
IT1252717B
IT1252717B ITRM910435A ITRM910435A IT1252717B IT 1252717 B IT1252717 B IT 1252717B IT RM910435 A ITRM910435 A IT RM910435A IT RM910435 A ITRM910435 A IT RM910435A IT 1252717 B IT1252717 B IT 1252717B
Authority
IT
Italy
Prior art keywords
pharmaceutical preparation
adjuvant treatment
seborrheic dermatitis
hiv positive
positive subjects
Prior art date
Application number
ITRM910435A
Other languages
English (en)
Inventor
Ferdinando Ippolito
Siro Passi
Original Assignee
Ist Fisioterap Ospitalroma
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ist Fisioterap Ospitalroma filed Critical Ist Fisioterap Ospitalroma
Priority to ITRM910435A priority Critical patent/IT1252717B/it
Publication of ITRM910435A0 publication Critical patent/ITRM910435A0/it
Priority to AT92830252T priority patent/ATE171375T1/de
Priority to ES92830252T priority patent/ES2122989T3/es
Priority to EP92830252A priority patent/EP0519876B1/en
Priority to DE69227072T priority patent/DE69227072T2/de
Priority to US07/892,190 priority patent/US5290809A/en
Publication of ITRM910435A1 publication Critical patent/ITRM910435A1/it
Application granted granted Critical
Publication of IT1252717B publication Critical patent/IT1252717B/it

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00Medicinal preparations containing inorganic active ingredients
    • A61K33/04Sulfur, selenium or tellurium; Compounds thereof

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Inorganic Chemistry (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Steroid Compounds (AREA)

Abstract

Si descrive una preparazione farmaceutica da utilizzare come trattamento coadiuvante della dermatite seborroica anche in soggetti HIV positivi che impiega come principi attivi metionina, Vit.E e Selenio, che concorrono direttamente o indirettamente a fornire una risposta protettiva sui danni da lipoperossidazione e di riflesso, in associazione ad una dieta ricca di PUFA-PL, (acidi grassi polinsaturi dei fosfolipidi), permettono di assicurare il ripristino dell'omeostasi cutanea, con la regressione della sintomatologia della dermatite cutanea.
ITRM910435A 1991-06-18 1991-06-18 Preparato farmaceutico da utilizzare quale trattamento coadiuvante della dermatite seborroica anche in soggetti hiv positivi IT1252717B (it)

Priority Applications (6)

Application Number Priority Date Filing Date Title
ITRM910435A IT1252717B (it) 1991-06-18 1991-06-18 Preparato farmaceutico da utilizzare quale trattamento coadiuvante della dermatite seborroica anche in soggetti hiv positivi
AT92830252T ATE171375T1 (de) 1991-06-18 1992-05-22 Pharmazeutische zusammensetzung, die als hilfsmittelbehandlung von seborrhoid-dermatitis, auch bei hiv-patienten, verwendbar ist
ES92830252T ES2122989T3 (es) 1991-06-18 1992-05-22 Una preparacion farmaceutica para tratamiento coadyuvante de la dermatitis seborreica incluso en sujetos seropositivos y su uso.
EP92830252A EP0519876B1 (en) 1991-06-18 1992-05-22 Pharmaceutical preparation to be used as adjuvant treatment of the seborrheic dermatitis even in HIV positive subjects
DE69227072T DE69227072T2 (de) 1991-06-18 1992-05-22 Pharmazeutische Zusammensetzung, die als Hilfsmittelbehandlung von Seborrhoid-Dermatitis, auch bei HIV-Patienten, verwendbar ist
US07/892,190 US5290809A (en) 1991-06-18 1992-06-02 Methods for the treatment of seborrheic dermatitis

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
ITRM910435A IT1252717B (it) 1991-06-18 1991-06-18 Preparato farmaceutico da utilizzare quale trattamento coadiuvante della dermatite seborroica anche in soggetti hiv positivi

Publications (3)

Publication Number Publication Date
ITRM910435A0 ITRM910435A0 (it) 1991-06-18
ITRM910435A1 ITRM910435A1 (it) 1992-12-18
IT1252717B true IT1252717B (it) 1995-06-26

Family

ID=11400207

Family Applications (1)

Application Number Title Priority Date Filing Date
ITRM910435A IT1252717B (it) 1991-06-18 1991-06-18 Preparato farmaceutico da utilizzare quale trattamento coadiuvante della dermatite seborroica anche in soggetti hiv positivi

Country Status (6)

Country Link
US (1) US5290809A (it)
EP (1) EP0519876B1 (it)
AT (1) ATE171375T1 (it)
DE (1) DE69227072T2 (it)
ES (1) ES2122989T3 (it)
IT (1) IT1252717B (it)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5292773A (en) * 1990-02-14 1994-03-08 Hirsch Gerald P Treating aids and HIV infection with methionine
GB2312621B (en) * 1996-05-02 1998-03-11 Pharma Nord Uk Limited Anti-oxidant medicament
US5667791A (en) * 1996-05-31 1997-09-16 Thione International, Inc. X-ray induced skin damage protective composition
IT1290907B1 (it) * 1997-01-31 1998-12-14 Idi Farmaceutici Spa Composizione per prodotto dietetico efficace nel combattere lo stress ossidativo e il decadimento cellulare.
US6138683A (en) * 1997-09-19 2000-10-31 Thione International, Inc. Smokeless tobacco products containing antioxidants
GB9722361D0 (en) * 1997-10-24 1997-12-17 Pharma Nord Uk Ltd Pharmaceutical formulation for treating liver disorders
US5922346A (en) * 1997-12-01 1999-07-13 Thione International, Inc. Antioxidant preparation
US6107349A (en) * 1998-04-16 2000-08-22 Mantynen; Philip R. Method and composition for treating psoriasis
US6670392B2 (en) * 2001-04-06 2003-12-30 Bioadvantex Pharma Inc. Compositions and methods for the prevention and treatment of human prostate cancer

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2244468A1 (en) * 1973-07-31 1975-04-18 Passwater Richard Anticarcinogenic food supplements - contg antioxidants and S-contg amino acids
SE8105887L (sv) * 1981-10-06 1983-04-07 Erland Johansson Blandning for human tillforsel av selen som sparemne
DE3332507A1 (de) * 1983-09-09 1985-03-28 Henkel Kgaa Sebosuppressive kosmetische mittel enthaltend benzylalkohol-derivate

Also Published As

Publication number Publication date
DE69227072D1 (de) 1998-10-29
EP0519876A1 (en) 1992-12-23
ATE171375T1 (de) 1998-10-15
ITRM910435A1 (it) 1992-12-18
US5290809A (en) 1994-03-01
EP0519876B1 (en) 1998-09-23
DE69227072T2 (de) 1999-03-18
ITRM910435A0 (it) 1991-06-18
ES2122989T3 (es) 1999-01-01

Similar Documents

Publication Publication Date Title
EP0295331A3 (en) Use of vitamin e for normalizing the blood coagulation in the therapy with omega-3-type highly unsaturated fatty acids
US4256763A (en) Treatment of herpes simplex infections and acne
AR013175A1 (es) Uso de bacteria de acido lactico para preparar una composicion oral para mamiferos util para facilitar la absorcion
IT1252717B (it) Preparato farmaceutico da utilizzare quale trattamento coadiuvante della dermatite seborroica anche in soggetti hiv positivi
BR0308799A (pt) co-glóbulos de dha e alecrim e método de uso
ES2040232T3 (es) Preparaciones medicinales para administracion oral conteniendo una sola dosis de 10 a 240 mg de dihidropiridina.
EP0249736A3 (en) Ointment for the treatment of skin diseases
ES2054353T3 (es) Expresion de las alipoproteinas humanas ai-milano en levadura.
CA2073913A1 (en) Preparation of fatty acid medicaments
MARTIN et al. Pityriasis rubra pilaris in the setting of HIV infection: clinical behaviour and association with explosive cystic acne
DK284386D0 (da) Farmaceutisk praeparat mod hudlidelser
AU2001261986A1 (en) Apoptotic entities for use in treatment of t-cell-mediated and inflammatory disorders
TNSN96005A1 (en) 2-(2-n-alcoxyphenyl)-purine-6-ones 9-substituees
DE3853427T2 (de) Behandlung gealterter haut mit oraler 13-cis-retinsäure.
CA2158591A1 (en) Fatty acid treatment
Finnerud PERLÈCHE: ITS NOSOLOGIC STATUS: CHAIRMAN'S ADDRESS
DE69018570T2 (de) Wasserlösliche Vitamin A-Zubereitungen und deren Verwendung bei der Hautbehandlung.
WO1999055347A3 (en) Treatment of papilloma virus infection using a mycobacterium
TNSN01033A1 (fr) Une composition pour la prevention et/ou le traitement des maladies vasculaires comportant le propionyl l- carnitine et la coenzyme q10.
吕维柏 Treatment of aids by traditional chinese medicine and materia medica
KR870005642A (ko) 디플루니살과 트로메타민의 혼합물
Schamberg Dermatitis of lower limb amputation stump
KR910002434A (ko) 레티노이드의 용도
Pettit PERSPECTIVES IN DERMATOLOGY: MALAYSIA.
BR102018071761A2 (pt) processo para a obtenção de pomada cicatrizante

Legal Events

Date Code Title Description
0001 Granted
TA Fee payment date (situation as of event date), data collected since 19931001

Effective date: 19950628